Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gushengtang Holdings Limited ( (HK:2273) ) has issued an announcement.
Gushengtang Holdings Limited reported that total customer visits reached approximately 1.392 million for the three months ended March 31, 2026, an increase of about 15% from roughly 1.21 million visits in the same period of 2025. The company said these operating figures are based on internal records and remain unaudited, cautioning shareholders and potential investors that final numbers in forthcoming periodical reports may differ and advising them to exercise care when dealing in its shares.
The latest data point to solid growth in patient volumes at Gushengtang’s clinics, underscoring continued demand for its healthcare services and suggesting positive operational momentum early in 2026. However, because the figures are preliminary and subject to change, investors may treat them as an early indicator rather than definitive performance, and the company’s call for caution highlights the usual uncertainty around unaudited short-term operating updates.
The most recent analyst rating on (HK:2273) stock is a Sell with a HK$24.50 price target. To see the full list of analyst forecasts on Gushengtang Holdings Limited stock, see the HK:2273 Stock Forecast page.
More about Gushengtang Holdings Limited
Gushengtang Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands and engaged in healthcare services, operating a network of clinics that provide medical treatment to a broad base of customers. The group focuses on growing its patient volumes and enhancing its presence in the regional healthcare market through expanding customer visits and service capacity.
Average Trading Volume: 1,429,762
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.56B
Find detailed analytics on 2273 stock on TipRanks’ Stock Analysis page.

